BRAFTOVI BREAKWATER Trial: Survival Results at ASCO 2025 ASCO 3 Mins Read Published: May 30, 2025 Pfizer shared results from the BRAFTOVI BREAKWATER trial at ASCO 2025. The trial tested BRAFTOVI® (encorafenib) with cetuximab…
FRESCO-2 Trial Meets Endpoints: Metastatic Colorectal Cancer Colorectal 15 Mins Read FRESCO-2 Trial Met Primary Endpoints in Patients With Metastatic Colorectal announced HUTCHMED from the Fruquintinib Global Phase III Trial The…
